Aucun résultat
Dr. Nathalie Johnson’s research focuses on the early detection and mechanisms of treatment resistance in lymphoma and on clinical trials of novel treatment treatment strategies for patients with newly diagnosed or relapsed lymphoma.
Dr. Nathalie Johnson is an associate professor in the departments of Medicine and Oncology and Director of the division of Hematology at McGill University. She holds the Louis Lowenstein Chair in Hematology & Oncology at McGill University. She is a hematologist at the Jewish General Hospital in Montreal who performs translational and clinical research since 2010. Her research focuses on studying mechanisms of therapeutic resistance to conventional and novel therapies and identifying early relapsed lymphoma using plasma circulating tumor DNA. She is the primary investigator of several clinical trials that test novel treatments for patients with newly diagnosed or relapsed lymphoma. She is also the program director for Clinical Investigator Program at McGill University and past President of the Canadian Society for Clinical Investigation (CSCI).
You have the power to make a difference! Your gift will support vital research at the Lady Davis Institute for Medical Research (LDI) that will translate into disease prevention, improved diagnoses, earlier detection, new and enhanced therapies, a better quality of life, wellness and hope for all of us.
Faire la différence, vous avez ce don! Votre contribution soutiendra la recherche essentielle menée à l’Institut Lady Davis qui permettra la prévention des maladies, des diagnostics plus précis, des dépistages plus rapides, des traitements innovants et plus performants, une meilleure qualité de vie, le bien-être et l’espoir pour nous tous.
Copyright © 2024 | Lady Davis Institute for Medical Research/Jewish General Hospital
Conception et développement : Yankee Media
